These data highlighted that the let-7b-HMGA2-CDKN2A axis regulates cell proliferation of leukaemic cells and could be a possible molecular target for the treatment of infant ALL with KMT2A-AFF1 [218]. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.